Category: HIV/AIDS

CROI 2019 – The Official UNMC ID Guide of Where We Will Be!

  CROI 2019 is here and we want to be sure YOU know where to find us in Seattle. Below is the list of faculty presentations and posters from our Division. Find us on Twitter @UNMC_ID  Content courtesy #CROI2019 http://www.croiconference.org/sites/default/files/uploads/croi2019-program-and-information.pdf  Oral presentations: Tuesday March 5 2019 (Oral Abstract O-05 STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF […]

Mar 5, 2019

Pharm to Exam Table: Doravirine DRIVES the way to more ART options

The Department of Health and Human Services HIV guidelines panel currently recommends antiretroviral therapy (ART) consisting of two nucleoside reverse transcriptase inhibitors plus an integrase inhibitor for most treatment naïve HIV infected individuals1.  Prior to the advent of integrase inhibitors, the utilization of non-nucleoside reverse transcriptase inhibitor (NNRTI) based regimens had been common.   Both efavirenz […]

Oct 15, 2018

Update for HIV Care Providers and Educators Revived and Reinvigorated!

Content written by Nikki Regan, APRN After a several year hiatus, the UNMC HIV Update conference was back and better than ever.  The conference planning committee at the UNMC/Nebraska Medicine Specialty Care Clinic started organizing this event over a year ago.  “The interest was definitely there,” said Ann Fitzgerald, APRN at the clinic and AIDS […]

Oct 12, 2018

At UNMC, ID fellows learn HIV from the experts

Over the course of their training, fellows in the UNMC’s Division of Infectious Diseases will receive dedicated clinical and didactic training in the area of HIV alongside faculty with expertise in the HIV clinical care and research. Clinical Training: Fellows will have their continuity clinic at UNMC’s HIV clinic one half day each week. The […]

Aug 30, 2018

Ending the AIDS epidemic with 90-90-90…Have YOU been tested?

Today is National HIV Testing Day, and one of the most fulfilling conversations to have with persons living with HIV (PLWH) is to share that since the 1980’s, we have made significant progress in the management of the AIDS epidemic. FDA approval of 27 antiretrovirals and 20 fixed dose combination antiretrovirals, increased HIV testing campaigns and […]

Jun 27, 2018

Pharm To Exam Table: Dual Antiretroviral Therapy with Dolutegravir + Lamivudine

Pharm To Exam Table: Dual Antiretroviral Therapy with Dolutegravir + Lamivudine Currently, triple therapy regimens constituted with a two nucleoside reverse transcriptase inhibitor backbone and anchored by an integrase inhibitor has been the standard treatment for HIV infection. However, these conventional therapies are being challenged due to their long-term side effects. Dual therapy regimens were […]

Jun 11, 2018

Pharm to Exam Table: Monoclonal Antibodies Make Their Way into HIV Treatment

Pharm to Exam Table: Clinical Pharmacology/Antimicrobial Updates – Trogarzo® (ibalizumab-uiyk), a new monoclonal antibody treatment approved for multi-drug resistant HIV-1  On March 6th 2018, the Food and Drug Administration approved a new monoclonal antibody called ibalizumab-uiyk, marketed under the tradename Trogarzo®. Ibalizumab-uiyk (IBA) is an intravenous treatment administered every two weeks. It is intended for use […]

May 11, 2018

EMET Student Profile – Rohan Khazanchi, M1

Tell us about the position you are starting? I will be joining the HIV Clinic over the next four years as a new HIV Enhanced Medical Education Track (EMET) student. Being in a longitudinal program like this means I will be returning to the HIV clinic throughout my medical training to learn about management of […]

Apr 16, 2018

UNMC ID Welcomes New M1 Enhanced Medical Education Track Students

The UNMC College of Medicine offers a unique Enhanced Medical Education Track (EMET) program which provides an opportunity for medical students to delve into particular disciplines of interest in the field of medicine throughout their four year degree program. Track students attend seminars, preceptorships and complete a research project culminating in a poster or conference […]

Apr 6, 2018

Pharm to Exam Table: Meet Biktarvy, the Newest of the Antiretroviral Family!

Pharm to Exam Table: Clinical Pharmacology/Antimicrobial Updates – Biktarvy, a new co-formulated integrase inhibitor-based treatment approved for HIV On February 7th 2018, the Food and Drug Administration approved a new combination antiretroviral drug called Biktarvy®(1). Biktarvy® (B/F/TAF) is a single-tablet, once daily regimen containing the novel integrase strand transfer inhibitor bictegravir coformulated with emtricitabine and tenofovir […]

Apr 2, 2018